HSK42360-Na Tablets Combined With Cetuximab With or Without Chemotherapy in BRAF V600-Mutant Metastatic Colorectal Cancer
A phase 1/2 trial of Cetuximab, CAPOX, FLOT in colorectal cancer, run by Haisco Pharmaceutical Group Co., Ltd., now recruiting.
Overview
HSK42360-Na Tablets Combined With Cetuximab With or Without Chemotherapy in BRAF V600-Mutant Metastatic Colorectal Cancer is a phase 1/2 interventional study registered as NCT07790510 by Haisco Pharmaceutical Group Co., Ltd., with 180 participants planned, started 2026-08-12 and due to reach its primary completion in 2029-09-30. Interventions recorded: HSK42360-Na Tablets, Cetuximab (EGFR inhibitor), mFOLFOX6 Regimen (Oxaliplatin/Leucovorin/5-FU), FOLFIRI Regimen (Irinotecan/Leucovorin/5-FU). Conditions listed: Metastatic Colorectal Cancer (CRC). No results are recorded here; the registry entry is the source.
Similar pages
not linked directly; found by shared links- TrialA Phase II Study of AMT-676 Combination Therapies in Advanced Colorectal Cancer
Shares FOLFIRI (5-FU, leucovorin, irinotecan), FLOT (5-FU, leucovorin, oxaliplatin, docetaxel), CAPOX (capecitabine, oxaliplatin), Cetuximab.
- TrialA Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer
Shares FOLFIRI (5-FU, leucovorin, irinotecan), FLOT (5-FU, leucovorin, oxaliplatin, docetaxel), CAPOX (capecitabine, oxaliplatin), Colorectal cancer.
- TrialA Study of AK112 With or Without AK117 in Metastatic Colorectal Cancer
Shares FOLFIRI (5-FU, leucovorin, irinotecan), FLOT (5-FU, leucovorin, oxaliplatin, docetaxel), CAPOX (capecitabine, oxaliplatin), Colorectal cancer.
- TrialPhase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Shares FLOT (5-FU, leucovorin, oxaliplatin, docetaxel), CAPOX (capecitabine, oxaliplatin), Colorectal cancer.
- TrialA Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer
Shares FOLFIRI (5-FU, leucovorin, irinotecan), FLOT (5-FU, leucovorin, oxaliplatin, docetaxel), Colorectal cancer.
- TrialBOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours
Shares FLOT (5-FU, leucovorin, oxaliplatin, docetaxel), CAPOX (capecitabine, oxaliplatin), Colorectal cancer.
- TrialA Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard
Shares FLOT (5-FU, leucovorin, oxaliplatin, docetaxel), CAPOX (capecitabine, oxaliplatin), Colorectal cancer.
- TrialStudy of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-muta
Shares FOLFIRI (5-FU, leucovorin, irinotecan), FLOT (5-FU, leucovorin, oxaliplatin, docetaxel), CAPOX (capecitabine, oxaliplatin).